A9552 Insurance Policy Changes

HCPCS A9552 is officially defined as "Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries." HCPCS A9552 is referenced in 3 tracked payer policy changes from Anthem BCBS and Humana. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS A9552 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Related

All billing codesJ35909921299213992029921499203

Get alerts for changes like this

Save a search and receive a daily digest whenever a new policy change matches your filters.

Create a free alert